Full title: A study evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Age: 18+
Phase: 1
Locations:
- Glasgow – The Beatson West of Scotland Cancer Centre
- Leeds – St James’s University Hospital
- London – The Royal Marsden
- Manchester – The Christie
- Newcastle – The Freeman Hospital
This study is a phase 1 trial looking at the drug AVA6000. Researchers want to understand its safety and side effects in people with advanced solid cancers, including soft-tissue sarcomas, that cannot be removed with surgery or have spread to other parts of the body. It is open to patients whose tumours are likely to be FAP-positive and who have limited treatment options.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
